Background addition, the segregation of the CNC into well-defined Cranial neural-crest cells (CNC) are critical for the normal migratory streams in Xenopus has recently been reported morphogenesis of the head and face in that they give rise to involve ephrin signaling, which is likely to provide to bone and cartilaginous elements as well as sensory spatial-boundary information critical for directing CNC neurons, glia, connective tissues, and some muscle. Neucells into the branchial arches [7, 8] . While cell surfaceral crest-cell migration is preceded by an epithelial-mesassociated protease activity is likely to play a role in reguenchymal transformation, which results in the emigration lating CNC adhesive and invasive behaviors, there is no of neural-crest cells from the neural ectoderm or neural direct evidence linking a neural crest-specific protease in tube. The signals that trigger this transformation and the these processes. subsequent directional migration of these cells are unclear, but changes in neural crest-cell adhesion are preADAMs are proteins that contain a disintegrin and a metsumed to play an important part. For example, trunk alloprotease domain [9] . Of the 31 known ADAMs, 18 neural-crest cells have been shown to downregulate are predicted to be active metalloproteases. Two generic N-cadherin expression [1] [2] [3] [4] and to increase their affinity for ECM molecules as they begin to migrate [5, 6] . In functions have been proposed for ADAM proteases: (1) Figure 1 local activation of signaling pathways by the shedding of cell surface cytokines and growth factors and (2) cell migration by degradation of the ECM [10, 11] . Although five ADAMs (numbers 9, 10, 12, 17, and 28) have been shown to act as metalloproteases in vitro, the only ADAMs that are known to be catalytically active in vivo are ADAMs 9, 10, and 17, which are all involved in shedding/ localized-signaling events. ADAM 9 is responsible for the shedding of HB-EGF from cultured cells [12] . ADAM 10 (kuzbanian) acts as a sheddase in the Notch signaling pathway [13] [14] [15] [16] . It also appears to function in both axon extension [17] and axon repulsion [18] . ADAM 10 promotes axon repulsion by releasing (shedding) an ephrin [18] . Its role (or that of another ADAM or matrix metalloprotease) in axon extension appears to be as a sheddase that releases the netrin receptor [19] . ADAM 17 (TACE) is involved in multiple ectodomain-shedding events, most notably the release of tumor necrosis factor [20, 21] .
Several observations suggest that ADAMs may function in cell migration. First, ADAM 10 and snake venom metalloproteases (SVMPs), the closest ADAM relatives, have been shown to cleave purified ECM components [22, 23] and their receptors [24] in vitro. Second, Xenopus ADAM 13 is expressed in cranial neural-crest cells [25] , a highly migratory population of cells that gives rise to a variety of tissues, including craniofacial cartilage and the cranial ganglia [26] [27] [28] [29] . Third, the secreted ADAM-like gene product, MIG-17, is required for the proper course of distal tip-cell migration in C. elegans [30] . Finally, fibroblasts use ␣6␤1 to migrate on a substrate containing the disintegrin domain of ADAM 9 at a more rapid rate than they do on a laminin substrate [31] .
While these studies point to the likely involvement of ADAMs in cell migration, there is no direct evidence linking ADAM protease activity with the adhesive and migratory behaviors of a specific cell population in vivo.
In this study we show that the metalloprotease activity . mAb 9E10 was used for the immunoprecipitation of Mycprocessing of ADAM 13 from its full-length 120 kDa precursor (P) tagged wild-type ADAM 13 from embryo extracts in the presence to its 100 kDa metalloprotease-active (M) form (1) . The second putative of 0.5 mM BB-3103. After the sample was washed in extraction buffer cleavage site between the protease and disintegrin domains is also containing BB-3103, one half of it was washed in extraction buffer represented (2) . (b) Western blot of stage 20 embryos extracted in without the inhibitor. After 2 hrs, Laemmli sample buffer was added ESB buffer in the absence (lane 1) or presence (lanes 2-3) of EDTA.
to both samples, and they were Western blotted with the 9E10 Incubation with the 6615F polyclonal antibody (directed against the antibody (lanes 6 and 7). Both pro and mature forms of ADAM 13 ADAM 13 cytoplasmic tail) reveals both precursor (P) and are visible in the presence of BB-3103 (lane 6), while the mature metalloprotease-active (M) forms of ADAM 13 after extraction in the form is degraded after the removal of BB-3103 (lane 7 ral crest (CNC)-cell migration has been described in detail We previously identified two major forms of ADAM 13 for this species [36] . During neurulation, CNC cells are in developing Xenopus embryos: a 120 kDa form and a located at the lateral edge of the neural plate. They con-100 kDa form. By analogy with other ADAMs [32-34], dense to form three segments (mandibular, hyoid, and these forms almost certainly represent precursor (P) and branchial), each of which migrates as a stream of cells presumptive metalloprotease-active (M) forms (Figure 1a) toward the ventral side of the embryo, with the branchial [25] . If tailbud stage embryos were extracted in a buffer segment further subdividing to yield a total of 4 distinct containing a nonionic detergent, we observed only the streams (e.g., see Figure 2k ,m). precursor form (Figure 1b) . If EDTA was added at the time of extraction, both the precursor and the presumptive To identify potential ADAM 13 gain-of-function phenometalloprotease-active forms were seen. If EDTA was types in embryos, we overexpressed the protein by inadded 30 min after extraction, degradation products of jecting synthetic transcripts encoding Myc-tagged wildthe presumptive metalloprotease-active form became aptype ADAM 13 into the animal pole of one blastomere parent (Figure 1b, arrow) . The presumptive metalloproat the two-cell stage. These injections resulted in the tease-active form is protected by the metalloprotease inoverexpression of ADAM 13 in CNC and also ectopic hibitors o-phenanthroline, TAPI [20] , and BB-3103 [35] .
expression of the protein in the neural tissue and the TAPI and BB-3103 are both hydroxamates that inhibit surrounding epidermis. The protein was rarely expressed ADAM and matrix metalloproteases; in this system BBin mesodermal derivatives, and this finding suggests that 3103 appears to be more potent (Figure 1c) . These data the mRNA did not diffuse far from the site of injection. suggest that there is a Zn (Figure 2d ,e, ure 1b,c), we engineered a point mutation in the active site blue arrowheads). These displaced cells do not express of the ADAM 13 metalloprotease domain; the catalytic the CNC-specific marker Xtwist [38] , and this observation glutamic acid (E) was changed to an alanine (A). Neurulaindicates that over-/ectopic expression of ADAM 13 does stage embryos expressing wild-type ADAM 13 and the not respecify trunk crest cells as cranial-crest cells ( Figure  E -to-A mutant (E/A) were then extracted in nonionic 2j). Instead, these cells (Figure 2d ,e, blue arrowheads) detergent. As seen above with embryos expressing wildtype ADAM 13, the 100 kDa presumptive metalloprolikely represent trunk neural-crest cells that have either tease-active form (M) was only seen if the extracts conemerged prematurely from the neural tube or that have tained EDTA. With embryos expressing the E/A mutant, failed to reach the midline because they were released however, the 100 kDa mature form was detected whether from the neural epithelium during neural-tube closure. the embryos were extracted in the presence or absence of EDTA (Figure 1d ). This result shows that the E/A Overexpression in Xenopus of ADAM 9 (Dr. Carl Blobel, personal communication) does not appear to affect neural mutant does not self degrade in detergent extracts like the wild-type ADAM 13 protein does. Collectively, these crest-cell development in this manner, as is evidenced by staining for Xslug. These findings indicate that the neuralfindings (Figure 1 ) indicate that ADAM 13 is a Zn 2ϩ -dependent metalloprotease and that substitution of an crest alterations discussed above are specific to ADAM 13 and are not likely to be a general consequence of overexpressing any ADAM with an active metalloprotease.
ADAM 13 metalloprotease activity is required for cranial neural crest-cell migration
In contrast to the amalgamated appearance of the cranial crest in embryo halves overexpressing wild-type ADAM 13 ( Figure 2d -f, red arrowheads), the three streams of CNC remained well resolved in embryo halves injected with the protease-defective E/A point mutant ( Figure  2g ,h). In most embryo halves expressing a protease-defective ADAM 13, however, it appeared that there was a reduction in the extent of ventrolateral migration of the CNC streams, particularly of the hyoid and branchial segments ( Figure 2h ). In addition, ectopic islands of Xslugstained cells were never observed in the trunks of embryo halves that express protease-defective E/A ADAM 13 ( Figure 2g,h ). This indicates that the observed displacement of the trunk neural-crest cells in wild-type ADAM 13-injected embryos is dependent on ADAM 13 metalloprotease activity. As with wild-type ADAM 13, there were no differences noted in patterns of Xslug expression in embryos expressing E/A ADAM 13 at the early neurula stage (Figure 2c ).
We determined that embryo-to-embryo variability in the severity of inhibition of cranial-crest migration following E/A ADAM 13 expression was probably due to variable amounts of E/A protein expressed at the cell surface. To increase the expression of this mutant construct at the cell surface, we exploited an observation that deletion of the cytoplasmic tail from ADAM 13 augments its surface expression by approximately 8-fold (data not shown), as has similarly been reported recently for ADAM 12 [39] . Indeed, the injection of synthetic transcripts encoding a protease-defective, cytoplasmic tail-minus version of ADAM 13 (E/A ⌬Cyto) produced a similar, but reproduci- tissues, including the trunk crest, that do not normally express ADAM 13 (Figure 2g-i) . Collectively, the results presented in Figure 2g -i suggest that metalloproteasedefective constructs of ADAM 13 act in a dominant-negative fashion to yield a cranial crest-specific loss-of-function phenotype, the inhibition of CNC-cell migration.
To determine whether the E/A mutant could indeed interfere with wild-type ADAM 13 proteolytic activity, as suggested by both the CNC-cell phenotype ( Figure 2 ) and by published data on ADAM 10 [15] , we have used a simple and well-defined gain-of-function phenotype induced by wild-type ADAM 13 overexpression and tested the ability of the E/A mutant to rescue this effect. As previously described [40], ADAM 13 overexpression (0.5 ng) induces cement gland expansion in 29% (n ϭ 78) of injected embryos. This phenotype is directly linked to the metalloprotease activity of ADAM 13 since no embryos injected with the E/A point mutant exhibited expanded cement glands. In contrast, when the same amount of wild-type transcript was coinjected with E/A ADAM 13 (0.5 ng), only 11% (n ϭ 85) of the embryos displayed altered cement glands. This result shows that the E/A mutant can interfere with wild-type ADAM 13 proteolytic activity and further suggests that this mutant can act as a dominant negative. Similar dominant-negative properties ase-defective ADAM 13 for Xtwist revealed a strong retardation in the progression of the hyoid and branchial CNC streams (Figure 2l ), and this finding reinforces the proposal that protease-defective forms of ADAM 13 can act wild-type ADAM 13; Figure 2d -f,j) and loss-of-function in a dominant-negative fashion in CNC cells. Migration (with protease-defective ADAM 13; Figure 2g -i,l) effects on an ADAM 13-driven process in neural-crest cells. An of the posterior margin of the manbidular CNC stream alternate possibility is that the observed changes are an did not appear to be affected by E/A ADAM 13 expresindirect consequence of disruptions in general neural patsion, and this finding suggests that an alternate, possibly terning or the result of alterations in normal neural crestcompensatory, mechanism is able to promote the migracell proliferation and/or specification. We conducted two tion of these particular cells when ADAM 13 function is sets of experiments to consider these possibilities. perturbed.
First, we stained for the neural markers Xsox-2 [37, 42] Effects of ADAM 13 over-/ectopic expression are specific to the neural crest and N-tubulin. Xsox-2 is expressed in the entire central We interpret the results presented in Figure 2 as evidence nervous system, while N-tubulin is restricted to future that the observed perturbations of CNC cells in embryos neurons. In embryo halves expressing wild-type ( Figure  3a ,c, black dot) or E/A (Figure 3b , black dot) ADAM expressing ADAM 13 are due to gain-of-function (with 13, staining for Xsox-2 was similar to that observed in is consistent with a model in which the normal function of ADAM 13 is to promote neural crest-cell migration. We uninjected control halves, with the exception of a lateral spot of staining at the level of the otic vesicle that was further propose that overexpression of protease-defective ADAM 13 impedes the normal progression of the CNC absent in embryo halves injected with wild-type ADAM 13 (Figure 3a,c) . This suggests that, aside from the otic cells by interfering with endogenous ADAM 13 metalloprotease activity. These experiments do not allow us to placode, neural development appeared normal in ADAM distinguish, however, whether the results observed are 13 transcript-injected embryos. Similarly, in situ hybriddue to a direct effect on the migration of neural-crest cells ization with N-tubulin at the neural plate stage revealed or whether an indirect effect on surrounding tissues leads a normal pattern of stripes for primary neurons in embryo to a subsequent perturbation of migration pathways. To halves expressing wild-type (Figure 3d, black dot) or E/A minimize the possible effects of ADAM 13 (ectopic) ex- (Figure 3e , black dot) ADAM 13. As observed for Xsox-2, pression in surrounding non-CNC tissues, we grafted a lateral spot of expression (Figure 3d ,e, arrowheads, unin-CNC cells [45] from neurula-stage embryos (stage 18) jected side) at the level of the trigeminal ganglion [43] injected with GFP alone or together with either wildwas absent in embryo halves injected with wild-type but type or E/A ADAM 13 (donor) into uninjected sibling not E/A ADAM 13 (compare Figure 3d,e, injected sides) . [15] . We also This suggests that the "fusion" of the CNC segments used the Xenopus Krox-20 probe to analyze the segmental observed in embryos overexpressing wild-type ADAM 13 organization of the hindbrain in embryos overexpressing (Figure 2d ,e) may be due to the ectopic expression (e.g., wild-type and E/A ADAM 13 [44] . In embryos injected in the ectoderm) of the protein rather than a function with wild-type (Figure 3f nostaining with the 9E10 anti-Myc mAb confirmed that these cells also expressed the Myc-tagged E/A ADAM 13 In a second set of experiments, we tested whether overexprotein (data not shown). This observation is in accord pression of wild-type or E/A ADAM 13 affects neural with previously described experiments in which Xtwist crest-cell proliferation and/or differentiation, which would staining of the mandibular CNC segment was observed be reflected in changes in levels of neural crest-cell marker in embryo halves expressing the E/A mutant (Figure 2l ). genes. Levels of Xslug and Xtwist mRNAs in embryos expressing wild-type ADAM 13 or the E/A mutant were These data suggest that ADAM 13 metalloprotease funcquantified by dot blot hybridization at early, mid, and tion is essential for CNC migration in the hyoid and late neurula stages and compared to those of uninjected branchial segments but not for cell migration in the mancontrols. In these quantitative experiments, no statistidibular segment. Time lapse movies of grafted embryos cally significant differences in the expression of these show that fluorescent CNC cells expressing the E/A muneural-crest markers were observed (data not shown).
tant tend to migrate anteriorly to the mandibular pathway These results suggest that the apparent increase in the or posteriorly to the vagal pathways rather than enter the Xslug signal observed with in situ hybridization at the hyoid and branchial pathways (example movies may be level of the CNC likely represents abnormal positioning found at http://faculty.virginia.edu/desimonelab/). These rather than an increased number of neural-crest cells.
results demonstrate that ADAM 13 metalloprotease function is required by CNC cells to permit their migration ADAM 13 function is required for cranial neural crest-cell migration through these pathways. Why the migration of CNC cells expressing E/A ADAM 13 is restricted to the mandibular Based on the results presented in Figures 2 and 3 , we conclude that over-/ectopic expression of ADAM 13 conpathway is unclear at present. It may be that migration through the hyoid and branchial arches requires the prostructs primarily affected neural crest-cell migration and not neural-crest growth and/or differentiation. Ectopic exteolytic processing of ECM molecules, which otherwise restrict the passage of these cells (see below). Because pression of wild-type ADAM 13 results in the appearance of trunk neural-crest cells in the lateral pathway, where the developing optic vesicle creates a "bulge" that may serve to physically separate the overlying ectoderm from the migration of these cells is normally restricted. This the labeled graft. Endogenous ADAM 13-dependent proteolytic activity associated with these wild-type "pioneer" cells may have been sufficient to open the mandibular pathway and may have thus allowed grafted E/A-expressing CNC cells to follow.
ADAM 13 alters cell adhesion on fibronectin
Taken together, the results presented in Figures 2-4 strongly suggest that ADAM 13 plays a critical role in CNC-cell migration in vivo. In order to address how this protein might affect cell migration, we have used two in vitro assays. The first one addresses the adhesion and migration capacity of mesodermal cells expressing ADAM 13 on a fibronectin substrate. These cells were chosen because they do not express detectable levels of ADAM 13 and because they migrate in a predictable fashion under these conditions [46] . Animal caps expressing either wildtype or the protease-defective E/A form of ADAM 13 were dissected from mid-blastula stage embryos and placed on fibronectin substrates in the presence of the mesoderminducer activin-A ( Figure 5 ). Under these conditions, noninjected control caps attached to the substrate and underwent convergence-extension movements (Figure 5a ). Cells in contact with the substrate at the periphery of the explant sent out lamellapodial extensions and spread and migrated as a cohesive sheet. Animal cap explants expressing wild-type ADAM 13 underwent convergence-extension movements, but cells in contact with the substrate, while remaining adherent, rounded-up, lost contact with their neighbors, and dispersed (Figure 5b,c) . This change in behavior was dependent on the metalloprotease activity of ADAM 13. When explants expressing ADAM 13 were cultured in the presence of the metalloprotease inhibitor (Figure 3) . the underlying mesenchymal tissue in the vicinity of the For example, both placodal induction and cement gland mandibular stream, it is possible that sufficient "space" specification require specific positive and negative signalis available to permit CNC-cell passage. Alternatively, ing between the ectoderm and the underlying tissue because the mandibular segment is the first to initiate [47] [48] [49] . ADAM 13 over-/ectopic expression may physi-CNC-cell migration, cells in this segment may not have all been removed from the host embryos prior to receiving cally interfere with these signals by decreasing cell-cell contacts. Interestingly, experimental separation of the active form of wild-type ADAM 13 is expressed at the cell surface (Figure 7b, right) . This is also the case for outer from the inner ectodermal layer by dissection is the E/A point mutant (Figure 7b, right) . Nontransfected sufficient to induce cement gland markers [50] . In our cells placed on a fluoresceinated fibronectin substrate adcase, ADAM 13 over-/ectopic expression may recapitulate hered and spread rapidly (Figure 6a ). After 14 hr, the this dissection in vivo at a cellular level. Similarly, ADAM fluorescent substrate was mostly intact (Figure 6aЈ ). In 13 over-/ectopic expression may block a positive signal contrast, transfected cells expressing high levels of wildnecessary for the induction of the trigeminal ganglion and type ADAM 13 ( Figure 6b ) modified extensively the fithe formation of the otic placode [51] .
bronectin substrate (Figure 6bЈ) . Alteration of the fibronectin substrate depended on the proteolytic activity of (Figure 6a and data not shown). Transient that this protein can inhibit endogenous ADAM 13 functransfection with Myc-tagged wild-type or mutant forms tion by acting as a dominant negative. of ADAM 13 resulted in expression of additional ADAM 13 protein at the cell surface (Figure 6b and 7b) . WildTo test whether ADAM 13 can cleave fibronectin directly, type ADAM 13-transfected XTC cells express both the we immunoprecipitated fibronectin from Xenopus plasma 120 kDa precursor (P) and the 100 kDa metalloproteaseby using the 4H2 mAb [46] and combined it with immunoactive (M) forms (Figure 7b, left) . Biotinylation experiprecipitated ADAM 13 in the absence (Figure 7c, lane 1) or presence (Figure 7c, lane 2) of the metalloprotease ments confirmed that only the 100 kDa metalloprotease- Together, these results indicate that ADAM 13 can refibronectin fragment, the formation of which is independent of ADAM 13.
model a fibronectin substrate and can cleave fibronectin at a preferred site. tion of a highly motile population of cells in vivo and that it may do so by modifying a component of the ECM.
Our results suggest that ADAM 13 may have several specific functions in cranial neural crest-cell migration (Figure 8) . First, ADAM 13 may help cells detach from the neuroepithelium by decreasing cell adhesion to the surrounding ECM (Figure 8a) . strate or by the tissue geometry of this particular region. This apparent requirement for ADAM 13 proteolytic activity in the hyoid and branchial segments but not in the mandibular segment also suggests that ADAM 13 function The ability to remodel a fibronectin substrate is a feature may help to "direct" CNC migration by unmasking potenof a number of cultured cells [52] [53] [54] [55] . Interestingly, fibrotial guidance cues along their migratory routes. Previous nectin remodeling is also increased after transformation studies in Xenopus have shown that proteins from the by v-src [56] , and increased levels of pp60Src are associEphrin family are involved in restricting the CNC to ated with matrix remodeling by invadopodia [57, 58] . We specific migratory pathways [7, 8] . Future work will inveshave recently reported that the ADAM 13 cytoplasmic tigate the possibility that ADAM 13 is involved in this domain can bind Xenopus Src proteins in vitro [40] . The process, possibly by releasing ephrins, as has been reported for ADAM 10 in axon repulsion [18] . results presented in the current study show that ADAM 13 is a metalloprotease expressed by a highly invasive population of cells in vivo (i.e., CNC cells) and that
Conclusion
ADAM 13 has the ability to remodel a fibronectin subIn summary, overexpression of wild-type ADAM 13 and strate when expressed in cultured cells. Together, these metalloprotease-defective forms of the protein has proresults suggest that ADAMs may be involved in the acquifound effects on the behavior of neural-crest cells in early sition of invasive properties by tumor cells. Future work Xenopus embryos as well as in animal cap explants and will address the possibility that Src proteins stimulate XTC cells cultured on fibronectin substrates in vitro. ADAM 13 metalloprotease activity.
Grafted CNC cells expressing the E/A "dominant-negative" ADAM 13 are restricted from the branchial and hyoid pathways. Our findings are consistent with a model
A model of ADAM 13 function in cell migration
in which the ADAM 13 protease functions in neural crestProteins of the ADAM family have been shown to act as cell adhesion and migration. Future work will address cell adhesion molecules and, through their metalloprothe substrate specificity of the ADAM 13 protease, the tease domains, as sheddases [10, 11, 59, 60] . It has also relative contributions of ADAM 13 metalloprotease activbeen proposed that ADAM metalloproteases may proity to matrix remodeling and cell signaling, and the possimote cell migration by degrading the ECM. Such an activ- provides evidence that an ADAM is involved in the migra- 
Transcript preparation and embryo injection
Mac version 1.2). The full-length coding region of Xenopus ADAM 13 [25] was cloned into the pCS2 transcription vector [62] . A point mutation substituting an alanine for glutamic acid 341 in ADAM 13 (E/A) was accomplished
Animal cap adhesion/migration assays
with the Stratagene Quick Change mutagenesis kit. Both the full-length Each blastomere at the two-cell stage was injected near the animal pole wild-type and E/A mutant constructs were also tagged with the Myc with 0.5 ng of synthetic transcripts. At the mid-blastula stage, the animal epitope at their C-termini so that expression could be followed with the cap regions of injected and noninjected control embryos were dissected 9E10 mAb (Santa Cruz Laboratories). The vector pCS2MycGFP was and placed on fibronectin substrates (20 g/ml coating concentration) in a generous gift from M. Klymkowsky (University of Colorado, Boulder).
the presence of 20 U/ml activin-A (kindly provided by D. Gospodarowicz, It has a single Myc upstream of the GFP and was made by Y. VourgourChiron Corporation) diluted in 60% L15 (Gibco/BRL). In some experiakis. All mRNAs were transcribed with SP6 polymerase after linearization ments, explants were cultured in the presence of 0.25 mM of the BBof plasmids with Not1 and were prepared for injection as described in 3103 protease inhibitor (British Biotech). Explants were cultured for 18 hr [40] . Transcripts (0.5 ng or 1 ng total) were injected close to the animal and photographed with a Leica M7Z dissecting scope or by interference pole region of one blastomere at the two-cell stage in order for the contrast with a Leitz (Fluovert FU) inverted microscope. targeting of ectoderm/neuroectoderm derivatives. The uninjected half of each embryo served as a control in all experiments. In some embryos, XTC cell transfection and fibronectin substrate assays the GFP transcript was injected alone as a control for the microinjection Xenopus XTC cells were grown in 60% L15 supplemented with 10% procedure.
fetal bovine serum, penicillin (10 IU/ml) and streptomycin (100 g/ ml) (Gibco BRL). Cells were transfected with the Fugene 6 reagent
Characterization of ADAM 13 processing
(Boehringer-Mannheim) according to the manufacturer's instructions.
and proteolytic activity
Transfected and control cells were grown for 48 hr after transfection, Injected and noninjected control embryos at neurula stages 18 or 20 detached with cold CMF (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , were solubilized in ESB buffer (100 mM NaCl, 50 mM Tris [pH 7.5], 15 mM HEPES [pH 7.6], 1% BSA), and plated on fluorescent fibronectin. 1% NP40, 2 mM PMSF) either in the presence or absence of 5 mM Fluorescent substrata were prepared as described in Avnur and Geiger EDTA. Solubilized glycoproteins were analyzed by Western blotting with [52] , with slight modification. Glass cover slips were coated with 100 the affinity-purified anti-ADAM 13 cytoplasmic-tail antibody (6615F) and g/ml of bovine FN (Sigma) and fluoresceinated with NHS-Fluoresceine ECL detection (Amersham), as described previously [25] . Embryos in-(Sigma) in 50 mM carbonate buffer (pH 9). Cells were left on fluorescent jected with 1 ng of transcripts encoding Myc-tagged constructs were fibronectin for 14 hr in complete culture media, fixed with 4% formaldeextracted in the presence of 5 mM EDTA or in the presence of the hyde in 1ϫ MBS, permeabilized with 0.5% Triton X-100 in PBS, and hydroxamate inhibitors TAPI (kindly provided by Dr. Roy Black at Imincubated in PBS containing 1% BSA and various antibodies. Secondary munex) or BB-3103 (kindly provided by British Biotech Pharmaceuticals anti-mouse IgG linked to Texas red (Molecular Probes) was diluted in Ltd.). Extracts were processed as above, but after Western blotting they PBS/1% BSA at 10 g/ml. Cells and substrates were imaged with a were probed with the 9E10 mAb. Five embryo equivalents per lane of Leica DMRXE confocal microscope (Leica TCS SP, 488/568 nm). material were analyzed for Western blotting with the 6615F antibody and 1 embryo equivalent per lane with 9E10.
Cell surface labeling of XTC cells was done with EZ-Link Sulfo-NHSBiotin (Pierce) in MBS at 1 mg/ml on live adherent cells for 20 min at room temperature. Biotinylated cells were washed with MBS containing
Whole-mount in situ hybridization and immunostaining 100 mM glycine (pH 7.5) and extracted in TBS, 1% Triton X-100, 2 mM Whole-mount in situ hybridization was carried out as described in Harland PMSF with 5 mM EDTA. Cellular debris was removed by centrifugation at [63] with slight modification [40] . Staining was performed with BM 13,000 rpm at 4ЊC for 15 min. Immunoprecipitations were done exactly Purple (Boerhinger-Mannheim) overnight at 20ЊC. Embryos were also as described in [66] with the 9E10 monoclonal antibody (SantaCruz immunostained with the 9E10 anti-Myc antibody (10 g/ml; Santa Cruz Laboratory) linked to Protein-G-agarose (Boehringer Manheim). BiotinylBiotechnology) as described in Hens and DeSimone [64] , with secondated proteins were detected with HRP-conjugated Streptavidin (Pierce) ary anti-mouse HRP conjugated-IgG (5 g/ml) and DAB staining. Emat 0.2 g/ml in TBS containing 0.1% Tween-20, followed by ECL treatbryos were then cleared in 1% H 2 O 2 and 0.5% formamide overnight ment as described above. under strong fluorescent light, dehydrated in 100% methanol, and mounted in benzyl benzoate/benzyl alcohol (2:1 vol/vol). Representative embryos were washed in methanol and embedded in polyethylene glycol
Cranial neural-crest transplantation 400-distearate (Aldrich), and serial 10 m sections were cut and Two cell-stage embryos injected with untagged-GFP (0.3 ng), GFP mounted in mowiol. Sense transcripts were used in parallel experiments (0.3 ng) plus wild-type ADAM 13 (0.7 ng), or GFP (0.3 ng) plus E/A as controls (data not shown). The cDNA templates used for the genera-ADAM 13 (0.7 ng) were cultured to neurula stages (17) (18) . Cranial tion of probes were generously provided by the following investigators:
neural-crest cells were transplanted from injected neurulae into uninXslug (Roberto Mayor), Xsox-2 (Robert Grainger), XCG (Hazel Sive), jected sibling embryos from which a comparable region of cranial neuralXkrox-20 (Thomas Lallier). Xtwist and N-tubulin were obtained by PCR crest had been removed (homotopic and homochronic) as described in from databank sequences and were cloned with the TOPO-TA cloning [45] . Photographs of transplanted embryos (stage 22-25) were taken kit (Invitrogen).
with a Zeiss dissecting scope equipped for epifluorescence. Immunostaining of the Myc-tagged wild-type and E/A ADAM 13 was performed as described above.
RNA spot blots
Total RNA from 10 embryos at various stages was extracted as in [65] and precipitated with LiCl. One half embryo equivalent of mRNA was
